Milestone Pharmaceuticals Inc. (MIST): Technical Analysis and analyst Ratings


Milestone Pharmaceuticals Inc. (NASDAQ:MIST) changes shares on Thursday trading session, with a change of 7.97% or $0.33 shares. The trading starts at $3.98 and closed at $4.08 throughout the day. The trading session low price was $3.93 and day high was $4.45 on Thursday, June 18. After the session, the Healthcare sector daily volume shifted to 0.65 million while its average volume is 2.11M. In other hand, the MIST market cap reached to $103.87M. While, its current target price is $4.41 according to WSJ.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 12.66% and up 33.48% for month. Its quarterly performance was -66.04% below, while its half year performance is down -72.16%. MIST yearly performance stood at negative -78.74% and fall -72.49% for year-to-date. Current recommendation for Milestone Pharmaceuticals Inc. is 2.70.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. MIST EPS (TTM) for 12-month is -2.40. EPS for this year is -256.90%, while for the next year its value is -2.22. Its EPS Q/Q reached -50.60%.

Let’s take a look on the analyst recommendations on MIST for the current month and previous month. For the current month, 1 of 4 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 3 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $3.00-$6.00. Average target price for MIST was reached at $4.00.

RTW Investments LP, Novo Holdings A/S and Boxer Capital, LLC are the top three holders in Milestone Pharmaceuticals Inc. (MIST) stock. On Mar 30, 2020, RTW Investments LP has 4.32 million shares which valued 7.94 million. On Mar 30, 2020, Novo Holdings A/S owned 2.08 million shares which valued at 3.83 million. On Mar 30, 2020, Boxer Capital, LLC has a total of 1.1 million shares which valued at 2.03 million. In the end, Boxer Capital, LLC have 4.48% shares outstanding of Milestone Pharmaceuticals Inc. (MIST) on Mar 30, 2020. The insider ownership moved to 1.60% and institutional holding shifted to 61.70%.

The company posted an EPS (TTM) of -2.40. According to the most recent quarter report on (Jun 2020), 4 analysts estimated an average EPS of -0.46, while -1.04 EPS posted a year ago period. Analyst Estimated EPS for MIST published in the report was -0.55–0.28 during the same period. Comparing with last year, the average estimated EPS was -1.04 which is lower than -0.67 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for MIST fall -68.55% for period of 200 days. SMA for 50 days was 38.73% which is showing green signal, while SMA-20 was 17.40%. The moving average value for Milestone Pharmaceuticals Inc. (MIST) is 11.5162 and 3.5406 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in MIST stock. On Mar 19, RTW INVESTMENTS, LP, 10% Owner, bought 5,870 trading shares at the cost of $10.87, which valued at 63804.0. On Mar 18, RTW INVESTMENTS, LP, 10% Owner, bought 2,705 shares at the cost of $10.36, with total shares of 4,309,232. On Mar 02, RTW INVESTMENTS, LP, 10% Owner, bought 78,263 shares at the cost of 18.95. After this transaction, RTW INVESTMENTS, LP total shares reached to 4,306,527 which valued at 1.48 million.